Lesionhunter
Payments companies reported to CMS as associated with Lesionhunter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lesionhunter, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lesionhunter
These are the largest totals companies reported as associated with Lesionhunter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bassem Matta | Wichita, KS | Gastroenterology (Internal Medicine) | $199.56 |
| Elena Nascimbeni Ferran | New York, NY | Gastroenterology (Internal Medicine) | $199.56 |
| Kohtaro Ooka | Bronx, NY | Gastroenterology (Internal Medicine) | $199.56 |
| David Poppers | New York, NY | Gastroenterology (Internal Medicine) | $199.56 |
| Nikhil Kumta | New York, NY | Gastroenterology (Internal Medicine) | $199.56 |
| Paul Akerman | Providence, RI | Gastroenterology (Internal Medicine) | $199.56 |
| Lauren Khanna | New York, NY | Gastroenterology (Internal Medicine) | $199.56 |
| Srihari Mahadev | New York, NY | Gastroenterology (Internal Medicine) | $199.56 |
| Steven Shamah | Chicago, IL | Gastroenterology (Internal Medicine) | $199.56 |
| Gregory Haber | New York, NY | Gastroenterology (Internal Medicine) | $199.56 |
Prescribed Lesionhunter?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.